REMSED Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Remsed, and what generic alternatives are available?
Remsed is a drug marketed by Bristol Myers Squibb and is included in one NDA.
The generic ingredient in REMSED is promethazine hydrochloride. There are twelve drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Remsed
A generic version of REMSED was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.
Summary for REMSED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Patent Applications: | 2,370 |
Formulation / Manufacturing: | see details |
DailyMed Link: | REMSED at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for REMSED
US Patents and Regulatory Information for REMSED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | REMSED | promethazine hydrochloride | TABLET;ORAL | 083176-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bristol Myers Squibb | REMSED | promethazine hydrochloride | TABLET;ORAL | 083176-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |